Monday, November 5, 2007

Key Points - NRM Medical Systems Roadmap

Due to the combination of personal compatibility with pharmaceutical effectiveness, it will be increasingly possible to harmonise the particular therapy with the patient's genetic makeup for drug metabolism, absorption, transport, and elimination, leading to a predictive medicine.

Nanoparticles will play one of the most important roles in future drug based therapy, due to their unique biological, chemical and physical properties.

The magnetic/ thermal behaviour of certain types of nanoparticles combined with other specific properties opens a wider spectrum of therapeutical methods such as nanoparticles based thermotherapy.

The deepened and more distinctive knowledge about the very specific acting agent, its predictable interaction with the target, its kinetic and predictable metabolism within the body in the forefront of any drug internalisation will lead to shortened experimentally validated approvals.

Against the background of an expected annual growth rate of the medical devices market by 5 -- 6% and medical imaging systems representing about 8 % of the total devices market7, this is a surprising result because the segments imaging tools and imaging agents, including contrast media and radiopharmaceuticals, can certainly benefit from an advanced technology, based on a deeper understanding of materials and cellular activities.

No comments: